Gamma Interferon and Interleukin-17A Differentially Influence the Response of Human Macrophages and Neutrophils to Pseudomonas aeruginosa Infection.


Journal

Infection and immunity
ISSN: 1098-5522
Titre abrégé: Infect Immun
Pays: United States
ID NLM: 0246127

Informations de publication

Date de publication:
02 2019
Historique:
received: 07 11 2018
accepted: 07 11 2018
pubmed: 21 11 2018
medline: 10 7 2019
entrez: 21 11 2018
Statut: epublish

Résumé

Macrophages are important orchestrators of inflammation during bacterial infection, acting as both effector cells and regulators of neutrophil recruitment and life span. Differently activated macrophage populations with distinct inflammatory and microbicidal potentials have been described. Our previous work unveiled a positive and a negative correlation between levels of gamma interferon (IFN-γ) and interleukin-17A (IL-17A), respectively, and lung function in cystic fibrosis, particularly in patients chronically infected with

Identifiants

pubmed: 30455194
pii: IAI.00814-18
doi: 10.1128/IAI.00814-18
pmc: PMC6346128
pii:
doi:

Substances chimiques

IL17A protein, human 0
Interleukin-17 0
Interferon-gamma 82115-62-6

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Medical Research Council
ID : MR/P001033/1
Pays : United Kingdom

Informations de copyright

Copyright © 2019 Muntaka et al.

Références

Nat Rev Immunol. 2010 Jun;10(6):427-39
pubmed: 20498669
J Leukoc Biol. 2010 Jan;87(1):93-106
pubmed: 20052802
Trends Immunol. 2013 Nov;34(11):521-30
pubmed: 23973621
Infect Immun. 2014 Oct;82(10):4204-11
pubmed: 25069982
J Immunol. 2013 Jun 15;190(12):6533-41
pubmed: 23667107
J Clin Invest. 2013 Apr;123(4):1630-7
pubmed: 23478406
Am J Pathol. 2010 Oct;177(4):1576-91
pubmed: 20813960
Nat Immunol. 2013 Jan;14(1):52-60
pubmed: 23160153
PLoS One. 2014 Mar 06;9(3):e89375
pubmed: 24603711
PLoS One. 2010 Nov 03;5(11):e13815
pubmed: 21082032
PLoS One. 2012;7(5):e37689
pubmed: 22649552
Nat Rev Immunol. 2006 Mar;6(3):173-82
pubmed: 16498448
Am J Respir Crit Care Med. 2016 Aug 15;194(4):415-28
pubmed: 27285640
J Immunol. 2012 Nov 1;189(9):4231-5
pubmed: 23024281
J Interferon Cytokine Res. 2001 Jul;21(7):485-94
pubmed: 11506742
Am J Physiol Lung Cell Mol Physiol. 2016 Nov 1;311(5):L1015-L1022
pubmed: 27694471
Eur J Immunol. 1996 Jun;26(6):1253-9
pubmed: 8647201
J Immunol. 1999 Jan 1;162(1):480-5
pubmed: 9886423
Clin Immunol. 2016 Sep;170:53-60
pubmed: 27155366
J Exp Med. 2011 Oct 24;208(11):2251-62
pubmed: 21967766
PLoS One. 2015 Mar 24;10(3):e0120912
pubmed: 25803862
J Exp Med. 2007 Dec 24;204(13):3235-45
pubmed: 18070936
Cell Cycle. 2014;13(9):1400-12
pubmed: 24626186
PLoS One. 2015 Feb 23;10(2):e0117447
pubmed: 25706389
Rheumatology (Oxford). 2010 Sep;49(9):1618-31
pubmed: 20338884
J Biol Chem. 2014 Apr 11;289(15):10812-22
pubmed: 24567336
Infect Immun. 2005 Jun;73(6):3693-701
pubmed: 15908399
Nature. 2012 Apr 25;484(7395):524-8
pubmed: 22538616
Proc Natl Acad Sci U S A. 2010 Jul 13;107(28):12564-9
pubmed: 20538976
PLoS One. 2011;6(9):e23637
pubmed: 21909403
Immunity. 2015 Jun 16;42(6):991-1004
pubmed: 26084020
PLoS Pathog. 2008 Sep 19;4(9):e1000159
pubmed: 18802458
Nat Med. 2015 Jul;21(7):677-87
pubmed: 26121197
Immunity. 2011 Dec 23;35(6):1023-34
pubmed: 22195750
Nat Rev Immunol. 2011 Jul 25;11(8):519-31
pubmed: 21785456
J Immunol. 2009 Dec 15;183(12):8088-98
pubmed: 19923470
J Leukoc Biol. 2011 May;89(5):675-83
pubmed: 21169518
Am J Physiol Lung Cell Mol Physiol. 2002 Feb;282(2):L285-90
pubmed: 11792633
EMBO Rep. 2010 Aug;11(8):640-6
pubmed: 20596075
Respirology. 2010 Oct;15(7):1037-56
pubmed: 20723140
Int J Obes (Lond). 2014 Nov;38(11):1440-8
pubmed: 24480860
Nat Med. 2013 Jun;19(6):713-21
pubmed: 23708291
Nat Immunol. 2014 Dec;15(12):1116-25
pubmed: 25326751
Nat Med. 2008 May;14(5):558-64
pubmed: 18438414
Am J Physiol Lung Cell Mol Physiol. 2015 Oct 15;309(8):L902-13
pubmed: 26472815
J Biol Chem. 2014 Feb 21;289(8):5320-9
pubmed: 24398679
Int Immunopharmacol. 2003 Sep;3(9):1247-55
pubmed: 12890422
Cytokine Growth Factor Rev. 2018 Jun;41:40-53
pubmed: 29655565
Nat Immunol. 2014 Feb;15(2):143-51
pubmed: 24362892
Nucleic Acids Res. 2011 Jan;39(Database issue):D596-600
pubmed: 20929876
Blood. 2010 Jan 14;115(2):335-43
pubmed: 19890092

Auteurs

Sirina Muntaka (S)

School of Life Sciences, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham, United Kingdom.

Yasir Almuhanna (Y)

School of Life Sciences, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham, United Kingdom.

Darryl Jackson (D)

School of Life Sciences, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham, United Kingdom.

Sonali Singh (S)

School of Life Sciences, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham, United Kingdom.

Afrakoma Afryie-Asante (A)

School of Life Sciences, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham, United Kingdom.

Miguel Cámara (M)

School of Life Sciences, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham, United Kingdom miguel.camara@nottingham.ac.uk luisa.m@nottingham.ac.uk.

Luisa Martínez-Pomares (L)

School of Life Sciences, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham, United Kingdom miguel.camara@nottingham.ac.uk luisa.m@nottingham.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH